Reboxetine
Links shared publicly online about this topic
Antidepressants: Benefit Of Reboxetine Not Proven
medicalnewstoday.com — “There is no scientific proof that people suffering from depression can benefit from taking reboxetine. however, clinical trials do provide proof of benefit of bupropion xl and mirtazapine: both ag” View full resource at medicalnewstoday.com
Most Recently Shared on November 26, 2009 at 11:34 am By:
MNT Depression News Health News
Antidepressants: Benefit Of Reboxetine Not Proven: There is no scientific proof that people suffering from depr.. http://bit.ly/4oqDBl
Antidepressants: Benefit Of Reboxetine Not Proven
medicalnewstoday.com — “There is no scientific proof that people suffering from depression can benefit from taking reboxetine. However, clinical trials do provide proof of benefit of bupropion XL and mirtazapine: both ag” View full resource at medicalnewstoday.com
Most Recently Shared on November 26, 2009 at 11:29 am By:
MNT Clinical Trials Health News
Antidepressants: Benefit Of Reboxetine Not Proven: There is no scientific proof that people suffering from depr.. http://bit.ly/68igr7
Psychiatry Article | Reboxetine
mdlinx.com — “Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial” View full resource at mdlinx.com
Most Recently Shared on February 22, 2011 at 6:41 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-contr... http://bit.ly/hfTROE #PSY
Antidepressant reboxetine no better than a placebo, study finds | Business | The Guardian
guardian.co.uk — “Scientists accuse Pfizer of holding back studies which reveal drug sold as Edronax to be ineffective and potentially harmful” View full resource at guardian.co.uk
Most Recently Shared on October 12, 2010 at 11:28 pm By:
Guardian Science Science Enthusiast
Antidepressant reboxetine no better than a placebo, study finds http://bit.ly/byD0hr
Pfizer's Antidepressant Reboxetine Doesn't Quell Illness, Analysis Find - Bloomberg
bloomberg.com — “Pfizer Inc. 's antidepressant reboxetine, sold for more than a decade in Europe, is no more effective than a placebo at treating symptoms of depression, according to an analysis that included unpublished studies.” View full resource at bloomberg.com
Most Recently Shared on October 13, 2010 at 1:16 pm By:
Jack Friday - PharmaGossip Health Blog
RT @stevesilberman: Antidepressant reboxetine works no better than placebo; Pfizer hid data - http://bit.ly/d5ELWf
The Whole Truth? Meta-Analysis of Reboxetine Trials Questions Veracity of All Industry-Sponsored Research - QualityPoint Technologies
qualitypointtech.net — “A meta-analysis of the antidepressant reboxetine is raising questions about the veracity of safety and efficacy data from all industry-sponsored trials. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 14, 2010 at 9:37 pm By:
The Whole Truth? Meta-Analysis of Reboxetine Trials Questions Veracity of All Industry-Sponsored Research: A meta-... http://bit.ly/cbRy66
The Crummiest Antidepressant You've Never Heard Of : Shots - Health News Blog : NPR
npr.org — “German researchers who analyzed clinical data for the Pfizer drug reboxetine conclude the medicine isn't effective for depression and may be harmful. Much of the information they reviewed hadn't been published.” View full resource at npr.org
Most Recently Shared on October 13, 2010 at 7:41 pm By:
The Crummiest Antidepressant You've Never Heard Of http://n.pr/bsKL29
Pfizer depression drug ineffective, may be harmful: study | Reuters
reuters.com — “LONDON (Reuters) - Pfizer's antidepressant reboxetine is an ineffective and potentially harmful drug and published data on it overestimates the benefits and underplays the risks, a study by German researchers” View full resource at reuters.com
Most Recently Shared on October 13, 2010 at 12:45 am By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Pfizer depression drug ineffective, may be harmful: study http://ow.ly/19pYbP
Pfizer depression drug ineffective, may be harmful: study | Reuters
reuters.com — “LONDON (Reuters) - Pfizer's antidepressant reboxetine is an ineffective and potentially harmful drug and published data on it overestimates the benefits and underplays the risks, a study by German researchers” View full resource at reuters.com
Most Recently Shared on October 13, 2010 at 12:36 pm By:
Jack Friday - PharmaGossip Health Blog
It's worse that that; the data was hidden RT @Reuters_Health: Pfizer depression drug ineffective, may be harmful: study http://dlvr.it/6ymX3
Brain Study Suggests Antidepressants 'Work Within Hours'
medicalnewstoday.com — “People who experience high levels of anxiety could benefit from a single high dose of a common antidepressant that has been shown to reduce anxiety within three hours. Dr Susannah Murph” View full resource at medicalnewstoday.com
Most Recently Shared on June 24, 2010 at 10:31 am By:
Peter H Brown Doctor and Psychologist
Brain Study Suggests Antidepressants 'Work Within Hours' http://mnt.to/f/3FhH #depression
Missing clinical trial data: setting the record straight -- Godlee and Loder 341 -- bmj.com
bmj.com — “Godlee, Fiona; Loder, Elizabeth” View full resource at bmj.com
Most Recently Shared on October 13, 2010 at 11:37 am By:
Jack Friday - PharmaGossip Health Blog
Biased evidence may form part of a marketing strategy. http://www.bmj.com/cgi/content/long/341/oct12_1/c5641
Neurology Medical News about Antidepressive Agents
mdlinx.com — “Reboxetine Enhances the Olanzapine-Induced Antipsychotic-Like Effect, Cortical Dopamine Outflow and NMDA Receptor-Mediated Transmission” View full resource at mdlinx.com
Most Recently Shared on May 15, 2010 at 12:32 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Reboxetine Enhances the Olanzapine-Induced Antipsychotic-Like Effect, Cortical Dopamine Outflow ... http://bit.ly/cHDah3 #neurology #mdlinx
Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients -- Harmer et al. 166 (10): 1178 -- Am J Psychiatry
ajp.psychiatryonline.org — “Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients -- Harmer et al. 166 (10): 1178 -- Am J Psychiatry” View full resource at ajp.psychiatryonline.org
Most Recently Shared on October 2, 2009 at 3:14 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Antidepressants improve emotional processing quickly in depressed patients. http://ow.ly/smei
Pfizer Accused of Lack of Disclosure - NYTimes.com
prescriptions.blogs.nytimes.com — “Published studies of 1,065 patients showed reboxetine worked. Unpublished studies of 3,033 showed it did not.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on October 14, 2010 at 4:11 pm By:
Prescriptions: Pfizer Accused of Lack of Disclosure http://nyti.ms/a4bwUC
More on Suppressed Clinical Trials | Psydir News
news.psydir.com — “We read in the BMJ that a German agency refuses to rule on drug's benefits until Pfizer discloses all trial results. The drug is reboxetine (Edronax), which readers will recall was recently deemed to be the worst new antidepressant by an Oxf...” View full resource at news.psydir.com
Most Recently Shared on July 18, 2009 at 5:52 pm By:
More on Suppressed Clinical Trials http://bit.ly/FlaHF
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Depression News
The latest depression news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
